Challenge of rehospitalizations for heart failure
Clinical development of pharmacologic agents for acute heart failure syndromes
Lessons learned from a pediatric clinical trial
Atrial fibrillation, anticoagulation, fall risk, and outcomes in elderly patients
Primary percutaneous coronary intervention for acute myocardial infarction: Is it worth the wait?
Design and rationale of the RadIal Vs. femorAL access for coronary intervention (RIVAL) trial
A randomized, partially blinded, multicenter, active-controlled, dose-ranging study assessing the safety, efficacy, and pharmacodynamics of the REG1 anticoagulation system in patients with acute coronary syndromes
Associations between cardiovascular parameters and uteroplacental Doppler (blood) flow patterns during pregnancy in women with congenital heart disease
Prehospital triage in the ambulance reduces infarct size and improves clinical outcome
The influence of time from symptom onset and reperfusion strategy on 1-year survival in ST-elevation myocardial infarction
Has the ClOpidogrel and Metoprolol in Myocardial Infarction Trial (COMMIT) of early β-blocker use in acute coronary syndromes impacted on clinical practice in Canada? Insights from the Global Registry of Acute Coronary Events (GRACE)
Incidence and clinical consequences of acquired thrombocytopenia after antithrombotic therapies in patients with acute coronary syndromes
Pregnancy in women with corrected tetralogy of Fallot
Left atrial reverse remodeling and functional improvement after mitral valve repair in degenerative mitral regurgitation
Certoparin versus unfractionated heparin to prevent venous thromboembolic events in patients hospitalized because of heart failure
A randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure
Effects of n-3 polyunsaturated fatty acids on malignant ventricular arrhythmias in patients with chronic heart failure and implantable cardioverter-defibrillators
Common oral mucosal diseases, systemic inflammation, and cardiovascular diseases in a large cross-sectional US survey
Reducing cardiovascular disease risk in medically underserved urban and rural communities
Incidence and clinical outcome of minor surgery in the year after drug-eluting stent implantation
Qualitative assessment of neointimal tissue after drug-eluting stent implantation
Standard versus high loading doses of clopidogrel in Asian ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention
Comparison of 2 point-of-care platelet function tests, VerifyNow Assay and Multiple Electrode Platelet Aggregometry, for predicting early clinical outcomes in patients undergoing percutaneous coronary intervention
Impact of baseline thrombocytopenia on the early and late outcomes after ST-elevation myocardial infarction treated with primary angioplasty
Temporal changes in the outcomes of patients with diabetes mellitus undergoing percutaneous coronary intervention in the National Heart, Lung, and Blood Institute dynamic registry
Clopidogrel loading dose and bleeding outcomes in patients undergoing urgent coronary artery bypass grafting
Factors associated with the physical activity level of children who have the Fontan procedure
Use of intensive lipid-lowering therapy in patients hospitalized with acute coronary syndrome
Correction
Correction
An important indirect drug interaction between dronedarone and warfarin that may be extrapolated to other drugs that can alter gastrointestinal function
Shirolkar's reply to Reiffel's letter to the editor